Literature DB >> 26314267

[Lysosomal storage diseases: A brief summary].

A Bornemann1, Klaus Harzer.   

Abstract

BACKGROUND: A considerable number of lysosomal storage diseases (LSD), which can occur at any age in life, should be included in the differential diagnosis of histiocytic diseases.
OBJECTIVE: To what extent can pathologists contribute to the diagnostics of LSD?
MATERIAL AND METHODS: In material collected from LSD, morphological storage phenomena in some disease forms, particularly in histiocytic cells from bone marrow smears and some tissues are highlighted, presented and described. Due to the multitude and heterogeneity of LSDs this list is by no means exhaustive.
RESULTS: In Gaucher disease, the forms of Niemann-Pick disease, cholesteryl ester storage disease (CESD), GM1 gangliosidosis and other LSDs, the histiocytic storage cells seen, for example, in bone marrow smears can be finely and ultrastructurally differentiated. Thereby, not only the presence of an LSD in general but also some individual types of LSD can be identified, even though preliminarily. To confirm the diagnosis the genetic and sometimes biochemical analysis of blood samples or fibroblast cultures from patients is usually required.
CONCLUSION: The pathologist may be the first to suspect LSD and this applies to LSDs that show storage histiocytes or one of a number of other LSDs in which only minor or absent storage is seen in histiocytes but marked storage phenomena are found in other cell systems. Some of the numerous, extremely heterogeneous LSDs may, however, be overlooked as detailed knowledge of the generally rare LSDs is the domain of LSD specialists. Clinicians, pathologists, geneticists and biochemists should cooperate in solving the diagnostic problems.

Entities:  

Mesh:

Year:  2015        PMID: 26314267     DOI: 10.1007/s00292-015-0053-8

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  8 in total

1.  Skin biopsy: a useful tool in the diagnosis of lysosomal storage diseases.

Authors:  Joseph Alroy; Angelo A Ucci
Journal:  Ultrastruct Pathol       Date:  2006 Nov-Dec       Impact factor: 1.094

Review 2.  Epidemiology and diagnosis of lysosomal storage disorders; challenges of screening.

Authors:  Sandra D K Kingma; Olaf A Bodamer; Frits A Wijburg
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2014-08-26       Impact factor: 4.690

3.  The autophagic defect in Niemann-Pick disease type C neurons differs from somatic cells and reduces neuronal viability.

Authors:  Volker Meske; Jennifer Erz; Timm Priesnitz; Thomas-Georg Ohm
Journal:  Neurobiol Dis       Date:  2014-01-09       Impact factor: 5.996

4.  Hepatosplenomegalic lipidosis: what unless Gaucher? Adult cholesteryl ester storage disease (CESD) with anemia, mesenteric lipodystrophy, increased plasma chitotriosidase activity and a homozygous lysosomal acid lipase -1 exon 8 splice junction mutation.

Authors:  S vom Dahl; K Harzer; A Rolfs; B Albrecht; C Niederau; C Vogt; S van Weely; J Aerts; G Müller; D Häussinger
Journal:  J Hepatol       Date:  1999-10       Impact factor: 25.083

5.  Atypical cytomorphology of Gaucher cells is frequently seen in bone marrow smears from untreated patients with Gaucher disease type 1.

Authors:  Alicja Markuszewska-Kuczynska; Monika Klimkowska; Sofie Regenthal; Agnes Bulanda; Cecilia Kämpe Björkvall; Maciej Machaczka
Journal:  Folia Histochem Cytobiol       Date:  2015-03-04       Impact factor: 1.698

6.  Greater risk of parkinsonism associated with non-N370S GBA1 mutations.

Authors:  M J Barrett; P Giraldo; J L Capablo; P Alfonso; P Irun; B Garcia-Rodriguez; M Pocovi; G M Pastores
Journal:  J Inherit Metab Dis       Date:  2012-09-12       Impact factor: 4.982

Review 7.  Gangliosides and gangliosidoses: principles of molecular and metabolic pathogenesis.

Authors:  Konrad Sandhoff; Klaus Harzer
Journal:  J Neurosci       Date:  2013-06-19       Impact factor: 6.167

Review 8.  Fabry disease.

Authors:  Dominique P Germain
Journal:  Orphanet J Rare Dis       Date:  2010-11-22       Impact factor: 4.123

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.